Michele Baccarani Selected Research

Imatinib Mesylate (Gleevec)

1/2021	Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
1/2020	High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
8/2017	The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
7/2017	Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
5/2017	No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.
1/2017	Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
1/2017	A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
1/2017	Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia.
10/2016	Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.
7/2016	Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michele Baccarani Research Topics

Disease

132	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 02/2002
33	Philadelphia Chromosome 01/2022 - 02/2002
24	Neoplasms (Cancer) 01/2017 - 04/2002
24	Multiple Myeloma 03/2012 - 04/2002
22	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2002
18	Leukemia 01/2021 - 09/2002
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2020 - 05/2002
17	Lymphoma (Lymphomas) 12/2013 - 08/2002
14	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2013 - 02/2002
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2011 - 02/2002
10	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 09/2003
10	Blast Crisis (Blast Phase) 10/2016 - 03/2003
8	Thrombocytopenia (Thrombopenia) 01/2016 - 02/2002
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2011 - 03/2005
7	Neutropenia 01/2016 - 05/2003
7	Infections 06/2013 - 09/2004
6	Exanthema (Rash) 01/2022 - 02/2012
6	Chromosome Aberrations (Chromosome Abnormalities) 11/2019 - 10/2007
6	Pathologic Complete Response 02/2009 - 11/2002
5	Residual Neoplasm 01/2021 - 02/2002
5	Disease Progression 08/2015 - 03/2002
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2015 - 03/2002
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2011 - 05/2005
4	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 12/2013 - 05/2003
4	Hypereosinophilic Syndrome (Loeffler Endocarditis) 12/2013 - 02/2004
4	Acute Promyelocytic Leukemia 05/2011 - 11/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 03/2011 - 05/2003
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2008 - 02/2002
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2008 - 11/2003
3	Pleural Effusion (Pleural Effusions) 01/2018 - 02/2012
3	Pancreatitis 01/2016 - 12/2009
3	Arthralgia (Joint Pain) 01/2016 - 05/2003
3	Thrombosis (Thrombus) 09/2015 - 04/2009
3	Hodgkin Disease (Hodgkin's Disease) 01/2012 - 08/2002
3	Essential Thrombocythemia 04/2009 - 11/2004
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 09/2007 - 09/2005
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2007 - 10/2003
2	Bronchiolitis Obliterans Syndrome 01/2022 - 06/2008
2	Hypertension (High Blood Pressure) 04/2017 - 01/2016
2	Systemic Mastocytosis 11/2015 - 10/2007
2	Diarrhea 11/2015 - 05/2012
2	Primary Myelofibrosis (Myelosclerosis) 08/2015 - 04/2009
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 12/2013 - 08/2004
2	Edema (Dropsy) 05/2012 - 02/2012
2	Myalgia 05/2012 - 02/2012

Drug/Important Bio-Agent (IBA)

102	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 02/2002
65	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2004
26	nilotinib FDA Link 10/2022 - 06/2007
22	Rituximab (Mabthera)FDA Link 12/2013 - 02/2002
20	Dasatinib (BMS 354825)FDA Link 01/2018 - 11/2006
16	Phosphotransferases (Kinase)IBA 01/2021 - 06/2005
15	Pharmaceutical PreparationsIBA 01/2020 - 01/2004
14	Thalidomide (Thalomid)FDA Link 03/2012 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 10/2019 - 04/2002
13	Interferon-alpha (Interferon Alfa)IBA 10/2010 - 03/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 03/2012 - 09/2002
11	bcr-abl Fusion ProteinsIBA 01/2011 - 02/2002
10	fludarabineIBA 12/2013 - 12/2003
8	Inosine Triphosphate (ITP)IBA 01/2013 - 02/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2011 - 05/2004
6	ponatinibIBA 01/2022 - 09/2014
6	Etoposide (VP 16)FDA LinkGeneric 07/2020 - 08/2002
6	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2020 - 11/2002
6	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2020 - 07/2004
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 06/2003
6	Prednisone (Sone)FDA LinkGeneric 08/2010 - 09/2002
5	HomoharringtonineIBA 01/2016 - 07/2013
5	Bortezomib (Velcade)FDA Link 01/2015 - 08/2006
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2012 - 10/2004
5	Vincristine (Oncovin)FDA LinkGeneric 08/2010 - 05/2004
4	SteroidsIBA 01/2022 - 02/2004
4	Hemoglobins (Hemoglobin)IBA 11/2019 - 11/2003
4	Lipase (Acid Lipase)FDA Link 01/2016 - 12/2009
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2011 - 11/2002
4	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2011 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010 - 05/2005
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2014 - 04/2009
3	TOPSIBA 01/2014 - 05/2012
3	EnzymesIBA 02/2013 - 12/2009
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2013 - 04/2007
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 12/2008
3	InterferonsIBA 07/2011 - 03/2003
3	Yttrium-90IBA 08/2010 - 02/2008
3	ibritumomab tiuxetan (Zevalin)FDA Link 08/2010 - 02/2008
3	Ifosfamide FDA LinkGeneric 11/2008 - 08/2002
3	Epirubicin (Ellence)FDA LinkGeneric 11/2008 - 08/2002
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2007 - 06/2005
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2016
2	Busulfan (Busulfex)FDA Link 01/2014 - 04/2009
2	AntibodiesIBA 06/2013 - 05/2003

Therapy/Procedure

79	Therapeutics 11/2022 - 04/2002
26	Drug Therapy (Chemotherapy) 09/2011 - 02/2002
19	Stem Cell Transplantation 05/2013 - 04/2002
9	Autologous Transplantation 12/2011 - 05/2003
7	Transplantation 08/2010 - 09/2003
5	Hematopoietic Stem Cell Transplantation 01/2017 - 12/2006
5	Salvage Therapy 12/2013 - 04/2002
3	Splenectomy 06/2013 - 06/2008
3	Radioimmunotherapy 08/2010 - 02/2008
3	Radiotherapy 11/2007 - 07/2003